Silver Book Fact

Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.

Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman. Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics. Health Affairs. 2007; 26(1): 62-74

Reference

Title
Curbing The Cardiovascular Disease Epidemic: Aligning industry, government, payers, and academics
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Califf, Robert M., Robert A. Harrington, Leanne K. Madre, Eric D. Peterson, Deborah Roth, and Kevin A. Schulman
Volume & Issue
Volume 26, Issue 1
Pages
62-74

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Using technologies as treatment for heart disease helps generate cost savings, including a total of $1930 annual savings per person, and a $1.5 billion increased tax revenue  
  • Since 1950, reduction in heart disease mortality has added more than 3 1/2 years to the expected lifetimes of both men and women.  
  • Performing renal angioplasty to unclog arteries costs $6,000 less than performing a surgical bypass operation. When post-procedure costs are factored in, it costs $14,000 less. The performance of renal angioplasty…  
  • Survival Rates of SAS Patients with and without SAVR
    Patients with severe aortic stenosis (SAS) ages 80+ who underwent surgical aortic valve replacement (SAVR) have 1-year, 2-year, and 5-year survival rates of 87%, 78%, and 68% respectively — compared with…  
  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…